查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948690

糖尿病鞋市场－全球产业规模、份额、趋势、机会和预测：按产品类型、最终用户、分销管道、地区和竞争格局划分，2021-2031年

Diabetic Footwear Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Slippers, Sandals, Shoes), By End User (Male, Female), By Distribution Channel (Direct, Indirect), By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球糖尿病鞋市场预计将从 2025 年的 89.7 亿美元成长到 2031 年的 139.7 亿美元，复合年增长率为 7.66%。

这些专业的治疗性鞋类产品旨在减少神经病变和血液循环不良患者的皮肤损伤并预防溃疡。其主要成长要素包括糖尿病盛行率的上升、全球人口老化导致下肢截肢预防措施需求的增加，以及医疗机构对主动足部护理管理的日益重视。

市场概览
预测期 2027-2031
市场规模：2025年 89.7亿美元
市场规模：2031年 139.7亿美元
复合年增长率：2026-2031年 7.66%
成长最快的细分市场 鞋
最大的市场 北美洲

然而，新兴经济体中成本效益低的报销政策和治疗性鞋类的高昂价格是市场扩张的主要障碍。这些经济障碍往往使患者无法获得所需产品，阻碍了开发中国家的普及。儘管有这些限制，潜在基本客群依然庞大。根据国际糖尿病联盟预测，到2024年，全球将有约5.89亿成年人患有糖尿病，凸显了特定足部护理干预措施的巨大市场规模。

市场驱动因素

全球糖尿病盛行率的不断上升是推动糖尿病鞋市场成长的主要动力，因为用于应对相关併发症的预防性医疗保健产品变得至关重要。这种慢性疾病的蔓延给医疗保健系统带来了越来越大的财政压力，凸显了采取有效干预措施以避免截肢等高昂后果的必要性。其经济影响巨大，美国糖尿病协会 (ADA) 在 2024 年 1 月报告称，美国确诊糖尿病的总费用估计已达 4,129 亿美元。这项支出凸显了专用鞋的重要性，同时也显示潜在患者群仍然庞大。正如 Umbra Healthcare 在 2024 年 4 月指出的那样，糖尿病足溃疡每年影响约 2.5% 的糖尿病患者，这更凸显了防护鞋的临床需求。

此外，人体工学设计技术的进步正推动市场从纯粹的功能性鞋履向整合式感测器的先进解决方案转型。製造商正在将智慧技术应用于足部健康持续监测，包括压力分布和温度追踪，以预防压疮。目前，该领域的创新正获得大量投资；例如，Orpyx Medical Technologies 于 2024 年 9 月获得 2,000 万美元的成长资金，用于扩展其远端监测感测器鞋垫系统。这些技术投资将透过提升舒适度来提高患者的依从性，并提供数据驱动的洞察，使医疗保健提供者能够实施积极主动的肢体保护护理。

市场挑战

全球糖尿病鞋市场面临的主要挑战是保险覆盖范围不均和治疗产品高成本，尤其是在新兴经济体。儘管临床上对预防性鞋的需求十分迫切，但患者的经济负担往往阻碍了这种需求转化为实际的市场需求。在许多发展中地区，医疗系统优先考虑急性治疗而非预防策略，迫使患者自费承担整形外科鞋的全部费用。这种自付费用对低收入族群来说是一大障碍，也阻碍了潜在需求量大的地区的市场渗透。

医疗资源严重偏向治疗现有併发症而非预防併发症，加剧了经济挑战。庞大的支出规模给全球预算带来压力，并限制了可用于支持辅助器具（併发症特製鞋）的资金。根据国际糖尿病联盟（IDF）估计，到2024年，全球糖尿病医疗支出将达到1.015兆美元。如此巨大的财政负担表明，除非拨出专款用于预防，否则在对成本敏感的地区，糖尿病鞋市场将难以充分发挥其商业性潜力。

市场趋势

在个人化矫正矫正器具製造领域采用3D列印技术，正引领此领域从传统机械加工转型为精准数位化製造。这项创新能够生产出密度可变的定製鞋垫，精准复製患者足部形状，显着降低足底压力负荷，从而预防压疮。根据《亚洲医疗保健》2025年7月刊报道，盛港综合医院的先导计画表明，院内3D列印的定製鞋垫与标准製造方法相比，可将足底峰值压力降低高达28.5%。这种高效性不仅改善了临床疗效，也简化了生产供应链，实现了设备的快速部署。

同时，时尚美学与治疗功能的融合正促使製造商重新设计整形外科产品，以减少患者的社会偏见并提高依从性。各公司正加强与设计界的合作，将深鞋楦和保护性鞋头等临床需求与现代、符合社会规范的时尚风格结合。 Darko International 于 2025 年 8 月宣布的策略合作是这一趋势的一个显着例证。该公司与萨凡纳艺术与设计大学 (SCAD) 的创新工作室 SCADpro 进行了为期 10 週的合作，16 名学生设计师共同打造了一个将先进的创伤护理功能与时尚鞋履相结合的全新概念。这凸显了该产业正朝着兼顾身体健康和生活方式偏好的产品方向转变。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：糖尿病患者鞋类全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依产品类型（拖鞋、凉鞋、鞋子）
    • 按最终用户（男性、女性）
    • 分销通路（直销、间接销售）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美糖尿病患者鞋类市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲糖尿病患者鞋类市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区糖尿病患者鞋类市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲糖尿病患者鞋类市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲糖尿病患者鞋类市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球糖尿病患者鞋类市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Podartis Srl
  • Aetrex, Inc.
  • Orthofeet, Inc.
  • Drewshoe, Inc.
  • DJO Global, Inc.
  • DARCO International, Inc.
  • Healer Health, LLC
  • Propet Footwear, Inc.
  • Finn Comfort USA Inc.
  • Apex Foot Health Industries, LLC

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 4264

The Global Diabetic Footwear Market is projected to expand from USD 8.97 Billion in 2025 to USD 13.97 Billion by 2031, reflecting a compound annual growth rate of 7.66%. These specialized therapeutic shoes are engineered to reduce skin breakdown and avert ulceration in individuals dealing with neuropathy or compromised circulation. Primary growth factors include the increasing prevalence of diabetes and an aging global population necessitating preventative solutions to avoid lower limb amputations, alongside a stronger focus by healthcare institutions on proactive foot care management.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 8.97 Billion
Market Size 2031USD 13.97 Billion
CAGR 2026-20317.66%
Fastest Growing SegmentShoes
Largest MarketNorth America

However, market expansion faces a significant hurdle due to inconsistent reimbursement policies and the high expense of therapeutic footwear in emerging economies. These financial barriers often limit patient access to necessary products and hinder widespread adoption in developing nations. Despite these constraints, the potential customer base remains extensive, as the International Diabetes Federation reported approximately 589 million adults living with diabetes worldwide in 2024, underscoring the massive scale of the market requiring specific foot care interventions.

Market Driver

The rising global incidence of diabetes serves as the main catalyst for the diabetic footwear market's growth, necessitating preventative medical products to handle related complications. As this chronic condition becomes more prevalent, healthcare systems encounter increasing financial pressures, driving the need for effective interventions to avoid costly outcomes such as amputations. The economic impact is profound; according to the American Diabetes Association in January 2024, the total estimated cost of diagnosed diabetes in the United States alone hit $412.9 billion. This expenditure highlights the critical role of specialized footwear, while the addressable patient pool remains vast; Ambula Healthcare noted in April 2024 that diabetic foot ulcers impact nearly 2.5% of diabetic patients annually, reinforcing the clinical need for protective shoes.

Additionally, technological progress in ergonomic design is shifting the market from purely functional shoes to advanced, sensor-integrated solutions. Manufacturers are embedding smart technologies for continuous foot health monitoring, including pressure redistribution and temperature tracking, to prevent ulcers before they develop. This sector is drawing substantial investment to boost innovation; for instance, Orpyx Medical Technologies secured $20 million in growth capital in September 2024 to expand its sensory insole system for remote monitoring. These technological investments enhance patient compliance through improved comfort and provide data-driven insights that enable healthcare providers to deliver proactive limb preservation care.

Market Challenge

The central obstacle facing the Global Diabetic Footwear Market is the inconsistency of reimbursement coverage and the high cost of therapeutic products, especially within emerging economies. Although there is a strong clinical necessity for preventative footwear, the financial strain on patients frequently halts the conversion of this need into active market demand. In numerous developing regions, healthcare systems prioritize acute care over preventative strategies, forcing patients to cover the full cost of orthopedic shoes. This out-of-pocket expense acts as a significant barrier for lower-income populations, limiting market penetration in areas that otherwise hold considerable volume potential.

This economic challenge is intensified by the disproportionate allocation of healthcare resources toward managing existing complications rather than preventing them. The magnitude of spending demonstrates the pressure on global budgets, restricting available funds for subsidizing auxiliary items like specialized footwear. According to the International Diabetes Federation, diabetes accounted for an estimated USD 1.015 trillion in global health expenditure in 2024. This massive financial burden indicates that without specific funding allocated for prevention, the diabetic footwear market will encounter difficulties in realizing its full commercial potential in cost-sensitive regions.

Market Trends

The adoption of 3D printing technology for personalized orthotic manufacturing is transforming the sector by shifting from traditional subtractive methods to precise digital fabrication. This innovation allows for the production of custom insoles with variable densities that accurately map a patient's foot topography, thereby significantly improving pressure offloading to prevent ulceration. According to Healthcare Asia Magazine in July 2025, a pilot project by Sengkang General Hospital demonstrated that their in-house 3D-printed custom insoles decreased peak plantar pressure by up to 28.5% compared to standard manufacturing methods. This efficiency enhances clinical outcomes while also streamlining the production supply chain for rapid device deployment.

Concurrently, the convergence of fashion-forward aesthetics with therapeutic functionality is compelling manufacturers to redesign orthopedic products to lower patient stigma and boost compliance. Companies are increasingly collaborating with the design community to combine clinical necessities, such as extra depth and protective toe boxes, with modern, socially acceptable styles. A notable instance of this trend is Darco International, which reported in August 2025 the completion of a strategic 10-week collaboration with SCADpro, the innovation studio of the Savannah College of Art and Design. This partnership engaged 16 student designers to create fresh concepts that merge advanced wound care features with stylish footwear, highlighting the industry's shift toward products that support both physical health and lifestyle preferences.

Key Market Players

  • Podartis S.r.l.
  • Aetrex, Inc.
  • Orthofeet, Inc.
  • Drewshoe, Inc.
  • DJO Global, Inc.
  • DARCO International, Inc.
  • Healer Health, LLC
  • Propet Footwear, Inc.
  • Finn Comfort USA Inc.
  • Apex Foot Health Industries, LLC

Report Scope

In this report, the Global Diabetic Footwear Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diabetic Footwear Market, By Product Type

  • Slippers
  • Sandals
  • Shoes

Diabetic Footwear Market, By End User

  • Male
  • Female

Diabetic Footwear Market, By Distribution Channel

  • Direct
  • Indirect

Diabetic Footwear Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Diabetic Footwear Market.

Available Customizations:

Global Diabetic Footwear Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Footwear Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Slippers, Sandals, Shoes)
    • 5.2.2. By End User (Male, Female)
    • 5.2.3. By Distribution Channel (Direct, Indirect)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Diabetic Footwear Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By End User
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diabetic Footwear Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By End User
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Diabetic Footwear Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By End User
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Diabetic Footwear Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By End User
        • 6.3.3.2.3. By Distribution Channel

7. Europe Diabetic Footwear Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By End User
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diabetic Footwear Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By End User
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. France Diabetic Footwear Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By End User
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. United Kingdom Diabetic Footwear Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By End User
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Italy Diabetic Footwear Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By End User
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Diabetic Footwear Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By End User
        • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Diabetic Footwear Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By End User
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Diabetic Footwear Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By End User
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Diabetic Footwear Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By End User
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Diabetic Footwear Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By End User
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Diabetic Footwear Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By End User
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Diabetic Footwear Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By End User
        • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Diabetic Footwear Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By End User
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Diabetic Footwear Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By End User
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. UAE Diabetic Footwear Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By End User
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. South Africa Diabetic Footwear Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By End User
        • 9.3.3.2.3. By Distribution Channel

10. South America Diabetic Footwear Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By End User
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Diabetic Footwear Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By End User
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Colombia Diabetic Footwear Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By End User
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Argentina Diabetic Footwear Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By End User
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Diabetic Footwear Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Podartis S.r.l.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Aetrex, Inc.
  • 15.3. Orthofeet, Inc.
  • 15.4. Drewshoe, Inc.
  • 15.5. DJO Global, Inc.
  • 15.6. DARCO International, Inc.
  • 15.7. Healer Health, LLC
  • 15.8. Propet Footwear, Inc.
  • 15.9. Finn Comfort USA Inc.
  • 15.10. Apex Foot Health Industries, LLC

16. Strategic Recommendations

17. About Us & Disclaimer